Guidance for Medicis Pharmaceutical Corp. (MRX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2012 | $2.25 – 2.65 | $2.74 | $800.00M – 834.00M | $846.40M | = Maintained | Details |
| Q4 2012 | $0.72 – 0.95 | N/A | $216.00M – 235.00M | N/A | = Maintained | Details |
| Q3 2012 | $0.41 – 0.58 | $0.78 | $185.00M – 200.00M | $221.95M | = Maintained | Details |
| 2011 | $2.45 – 2.60 | $2.51 | $735.00M – 770.00M | $753.48M | = Maintained | Details |
| Q4 2011 | $0.63 – 0.69 | $0.70 | $187.00M – 200.00M | $199.00M | = Maintained | Details |
| Q2 2011 | $0.61 – 0.66 | $0.63 | $185.00M – 197.00M | $187.31M | = Maintained | Details |
| Q1 2011 | $0.45 – 0.50 | $0.61 | N/A | N/A | = Maintained | Details |
